TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinomaPavla Brachova, Kimberly K. Leslie|International Journal of Oncology|2014Cited by 97
EGFR isoforms and gene regulation in human endometrial cancer cellsLina Albitar, Kimberly K. Leslie|Molecular Cancer|2010Cited by 56
Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-TreatmentXiangbing Meng, Kimberly K. Leslie|PLoS ONE|2011Cited by 54
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial CancerAndrea R. Hagemann, Kimberly K. Leslie|Cancers|2025Cited by 12
Global expression analysis of endometrial cancer cells in response to progesterone identifies new therapeutic targetsKristina W. Thiel, Kimberly K. Leslie|The Journal of Steroid Biochemistry and Molecular Biology|2023Cited by 2